课题基金 / 基金详情

Analysis of the thyroid transcription factor-1(TTF-1) gene expression in thyroid neoplastic tissues.

Analysis of the thyroid transcription factor-1(TTF-1) gene expression in thyroid neoplastic tissues.
甲状腺肿瘤组织中甲状腺转录因子1(TTF-1)基因表达分析
批准号:
07671121
负责人:
ENDO Toyoshi
金额:
$1.47万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

ENDO Toyoshi的其他基金

相似基金

相关文献

中文摘要
翻译
研究了甲状腺转录因子-1(TTF-1)基因在甲状腺中表达的调控。我们发现了一个新的转录起始位点,位于核苷酸(ut)-1917处,在先前描述的位点上游-1700 bp处,并且该区域编码从nt -1242到-14作为第一内含子。用FRTL-5细胞mRNA进行的北方印迹分析显示,靶向外显子2的探针识别3.7和2.7 kb的转录本,而靶向未翻译的外显子1和第二内含子的两种探针仅检测到3.7 kb的转录本,这表明3.7 kb的mRNA是从nt-1917转录的,并且它包含sacond内含子。氯霉素乙酰转移酶(CAT)报告基因检测表明,该基因的5 '侧翼区在FRTL-5细胞中具有启动子活性,而在大鼠肝细胞中没有,表明该区域具有甲状腺特异性表达的特性。两个共识TTF-1的结合基序检测在这个启动子区域,电泳迁移率变动分析表明,寡核苷酸探针,每个含有这些基序之一,形成了一个复合物与重组TTF-1同源结构域。此外,重组TTF-1增加了缺乏TTF-1的细胞的转录活性。这些结果表明,转录从新确定的TTF-1基因的起始位点是正调控TTF-1在甲状腺。
英文摘要
Regulation of the thyroid transcription factor-1(TTF-1) gene expression in the thyroid was investigated. We identified a new transcription start site as nucleotide (ut)-1917, -1700 bp upstream of previously described site, and the region encom passing nt -1242 to -14 as the first intron. Northern blot analysis with FRTL-5 cell mRNA revealed that a probe targeted to exon 2 recognized 3.7 and 2.7 kb-transcripts, whereas both probes targeted to the untranslated exon 1 and the second intron deteced only the 3.7 kb-transcript, suggesting that the 3.7 kb-mRNA is transcribed from nt -1917 and that it contains the sacond intron. Chloramphenicol acetyltransferase (CAT) reporter gene assays demonstrated that the 5'-flanking region exhibited promoter activity in FRTL-5 cells but not in rat liver cells, indicating that this region confers the property of thyroid-specific exprression. Two consensus TTF-1 binding motifs were detected in this promoter region, and electrophoretic mobility-shift assays showed that oligonucleotide probes, each containing one of these motifs, formed a complex with the recombinant TTF-1 homeodomain. Moreover, recombinant TTF-1 increased the transcriptional activity in cells lacking TTF-1. These results suggest that transcriptional from the newly identified start site in the TTF-1 gene is positively regulated by TTF-1 in the thyroid.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathopysiology of fuluminant type 1 diabetes and development of its new therapy
  • 批准号:
    24591320
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.41万
  • 财政年份:
    2012
  • 负责人:
    ENDO Toyoshi
  • 依托单位:
Characterization of autoantibody against Amylaseα-2A in patients with fulminant type 1 diabetes mellitus and autoimmune pancreatitis, and its clinical use.
  • 批准号:
    21591127
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2009
  • 负责人:
    ENDO Toyoshi
  • 依托单位:
Early detection and diagnosis of fulminant type 1 diadetes mellitus
  • 批准号:
    19591041
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2007
  • 负责人:
    ENDO Toyoshi
  • 依托单位:
Organogenesis of pancreas in PDX-1 promoter/YFP transgenic mouse
  • 批准号:
    15590934
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    2003
  • 负责人:
    ENDO Toyoshi
  • 依托单位:
国内基金
海外基金
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
  • 批准号:
    82371145
  • 项目类别:
    面上项目
  • 资助金额:
    46.00万元
  • 批准年份:
    2023
  • 负责人:
    陶永
  • 依托单位:
转录因子BCL6抑制ICOSL表达优化生发中心反应的机制研究
  • 批准号:
    82371745
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    张文倩
  • 依托单位:
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
  • 批准号:
    82371704
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    徐步芳
  • 依托单位:
小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究